# Study of 23ME-01473 in Patients With Advanced Solid Malignancies

> **NCT06290388** · PHASE1,PHASE2 · TERMINATED · sponsor: **23andMe, Inc.** · enrollment: 5 (actual)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** 23ME-01473

## Key facts

- **NCT ID:** NCT06290388
- **Lead sponsor:** 23andMe, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-03-07
- **Primary completion:** 2024-11-10
- **Final completion:** 2024-11-10
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Sponsor cancelled study
- **Last updated:** 2024-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06290388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06290388, "Study of 23ME-01473 in Patients With Advanced Solid Malignancies". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06290388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*